Quantamental Technologies’s Aimmune Therapeutics AIMT Stock Holding History

Quantamental Technologies’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-6,994	Closed	-$241K	–	297
2020 Q3	$241K	Buy	+6,994	New	+$149K	0.18%	201
2019 Q3	–	Sell	-6,747	Closed	-$140K	–	1952
2019 Q2	$140K	Buy	+6,747	New	+$139K	0.05%	558

Quantamental Technologies's AIMT Position: Q4 2020 in Review

Quantamental Technologies sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 6,994 shares — an estimated $241K sold.

Quantamental Technologies first reported a position in AIMT in Q2 2019 and held it in 2 quarters. The position peaked at $241K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

Quantamental Technologies reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
Quantamental Technologies sold 6,994 Aimmune Therapeutics shares in Q4 2020, an estimated $241K.
Quantamental Technologies first reported a position in Aimmune Therapeutics in Q2 2019 and held it in 2 quarters.
Quantamental Technologies's Aimmune Therapeutics position peaked at $241K in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Quantamental Technologies's 13F filing for Q4 2020, filed 16 Feb 2021.